Comparison of serotonin glucuronidation activity of UDP-glucuronosyltransferase 1a6a (Ugt1a6a) and Ugt1a6b: Evidence for the preferential expression of Ugt1a6a in the mouse brain

Drug Metabolism and Pharmacokinetics

Volumn 28, Issue 3, 2013, Pages 260-264

  Uchihashi, Shinsuke ^a   Nishikawa, Miyu ^a   Sakaki, Toshiyuki ^a   Ikushiro, Shin Ichi ^a  

^a TOYAMA PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Serotonin; UDP glucuronosyl transferase (Ugt); Ugt1a6a; Ugt1a6b

Indexed keywords

GLUCURONOSYLTRANSFERASE 1A6; GLUCURONOSYLTRANSFERASE 1A6A; GLUCURONOSYLTRANSFERASE 1A6B; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; BRAIN; BRAIN REGION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; GLUCURONIDATION; HIPPOCAMPUS; LIVER; MALE; MOUSE; NONHUMAN; NOTE; PROTEIN EXPRESSION;

EID: 84879376658     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-12-NT-091     Document Type: Article

References (30)

1. Mackenzie, P. I., Bock, K. W., Burchell, B., Guillemette, C., Ikushiro, S., Iyanagi, T., Miners, J. O., Owens, I. S. and Nebert, D. W.: Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet. Genomics, 15: 677-685 (2005).
2. Uchihashi, S., Nishikawa, M., Sakaki, T. and Ikushiro, S.: The critical role of amino acid residue at position 117 of mouse UDP-glucuronosyltransfererase 1a6a and 1a6b in resveratrol glucuronidation. J. Biochem., in press.
3. Lamb, J. G., Straub, P. and Tukey, R. H.: Cloning and characterization of cDNAs encoding mouse Ugt1.6 and rabbit UGT1.6: differential induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochemistry, 33: 10513-10520 (1994).
4. Buckley, D. B. and Klaassen, C. D.: Tissue-and gender-specific mRNA expression of UDP-glucuronosyltransferases (UGTs) in mice. Drug Metab. Dispos., 35: 121-127 (2007).
5. Heydel, J. M., Holsztynska, E. J., Legendre, A., Thiebaud, N., Artur, Y. and Le Bon, A. M.: UDP-glucuronosyltransferases (UGTs) in neuroolfactory tissues: expression, regulation, and function. Drug Metab. Rev., 42: 74-97 (2010).
6. Martinasevic, M. K., King, C. D., Rios, G. R. and Tephly, T. R.: Immunohistochemical localization of UDP-glucuronosyltransferases in rat brain during early development. Drug Metab. Dispos., 26: 1039-1041 (1998).
7. Ghersi-Egea, J. F., Walther, B., Decolin, D., Minn, A. and Siest, G.: The activity of 1-naphthol-UDP-glucuronosyltransferase in the brain. Neuropharmacology, 26: 367-372 (1987).
8. Leclerc, S., Heydel, J. M., Amossé, V., Gradinaru, D., Cattarelli, M., Artur, Y., Goudonnet, H., Magdalou, J., Netter, P., Pelczar, H. and Minn, A.: Glucuronidation of odorant molecules in the rat olfactory system: activity, expression and age-linked modifications of UDP-glucuronosyltransferase isoforms, UGT1A6 and UGT2A1, and relation to mitral cell activity. Brain Res. Mol. Brain Res., 107: 201-213 (2002).
9. Petzold, G. C., Hagiwara, A. and Murthy, V. N.: Serotonergic modulation of odor input to the mammalian olfactory bulb. Nat. Neurosci., 12: 784-791 (2009).
10. Sullivan, J. M., Benton, J. L. and Beltz, B. S.: Serotonin depletion in vivo inhibits the branching of olfactory projection neurons in the lobster deutocerebrum. J. Neurosci., 20: 7716-7721 (2000).
11. King, C. D., Rios, G. R., Assouline, J. A. and Tephly, T. R.: Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate. Arch. Biochem. Biophys., 365: 156-162 (1999).
12. Bock, K. W. and Köhle, C.: UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects. Methods Enzymol., 400: 57-75 (2005).
13. Weissbach, H., Lovenberg, W., Redfield, B. G. and Udenfriend, S.: In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition. J. Pharmacol. Exp. Ther., 131: 26-30 (1961).
14. Uutela, P., Karhu, L., Piepponen, P., Käenmäki, M., Ketola, R. A. and Kostiainen, R.: Discovery of dopamine glucuronide in rat and mouse brain microdialysis samples using liquid chromatography tandem mass spectrometry. Anal. Chem., 81: 427-434 (2009).
15. Kasai, N., Sakaki, T., Shinkyo, R., Ikushiro, S., Iyanagi, T., Kamao, M., Okano, T., Ohta, M. and Inouye, K.: Sequential metabolism of 2,3,7-trichlorodibenzo-p-dioxin (2,3,7-triCDD) by cytochrome P450 and UDPglucuronosyltransferase in human liver microsomes. Drug Metab. Dispos., 32: 870-875 (2004).
16. Ikushiro, S., Emi, Y., Kato, Y., Yamada, S. and Sakaki, T.: Monospecific antipeptide antibodies against human hepatic UDP-glucuronosyltransferase 1A subfamily (UGT1A) isoforms. Drug Metab. Pharmacokinet., 21: 70-74 (2006).
17. Uchihashi, S., Fukumoto, H., Onoda, M., Hayakawa, H., Ikushiro, S. and Sakaki, T.: Metabolism of the c-Fos/activator protein-1 inhibitor T-5224 by multiple human UGT isoforms. Drug Metab. Dispos., 39: 803-813 (2011).
18. Fujino, K., Yoshitake, T., Inoue, O., Ibii, N., Kehr, J., Ishida, J., Nohta, H. and Yamaguchi, M.: Increased serotonin release in mice frontal cortex and hippocampus induced by acute physiological stressors. Neurosci. Lett., 320: 91-95 (2002).
19. Krishnaswamy, S., Duan, S. X., Von Moltke, L. L., Greenblatt, D. J., Sudmeier, J. L., Bachovchin, W. W. and Court, M. H.: Serotonin (5-hydroxytryptamine) glucuronidation in vitro: assay development, human liver microsome activities and species differences. Xenobiotica, 33: 169-180 (2003).
20. Krishnaswamy, S., Hao, Q., Von Moltke, L. L., Greenblatt, D. J. and Court, M. H.: Evaluation of 5-hydroxytryptophol and other endogenous serotonin (5-hydroxytryptamine) analogs as substrates for UDP-glucuronosyltransferase 1A6. Drug Metab. Dispos., 32: 862-869 (2004).
21. Brands, A., Münzel, P. A. and Bock, K. W.: In situ hybridization studies of UDP-glucuronosyltransferase UGT1A6 expression in rat testis and brain. Biochem. Pharmacol., 59: 1441-1444 (2000).
22. Auyeung, D. J., Kessler, F. K. and Ritter, J. K.: An alternative promoter contributes to tissue-and inducer-specific expression of the rat UDPglucuronosyltransferase 1A6 gene. Toxicol. Appl. Pharmacol., 174: 60-68 (2001).
23. Auyeung, D. J., Kessler, F. K. and Ritter, J. K.: Differential regulation of alternate UDP-glucuronosyltransferase 1A6 gene promoters by hepatic nuclear factor-1. Toxicol. Appl. Pharmacol., 191: 156-166 (2003).
24. Mackenzie, P. I., Gregory, P. A., Gardner-Stephen, D. A., Lewinsky, R. H., Jorgensen, B. R., Nishiyama, T., Xie, W. and Radominska-Pandya, A.: Regulation of UDP glucuronosyltransferase genes. Curr. Drug Metab., 4: 249-257 (2003).
25. Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M. and Gonzalez, F. J.: Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science, 268: 722-726 (1995).
26. Chan, K. and Kan, Y. W.: Nrf2 is essential for protection against acute pulmonary injury in mice. Proc. Natl. Acad. Sci. USA, 96: 12731-12736 (1999).
27. Enomoto, A., Itoh, K., Nagayoshi, E., Haruta, J., Kimura, T., O'Connor, T., Harada, T. and Yamamoto, M.: High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci., 59: 169-177 (2001).
28. Buckley, D. B. and Klaassen, C. D.: Induction of mouse UDPglucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab. Dispos., 37: 847-856 (2009).
29. Xu, J., Kulkarni, S. R., Li, L. and Slitt, A. L.: UDP-glucuronosyltransferase expression in mouse liver is increased in obesity-and fastinginduced steatosis. Drug Metab. Dispos., 40: 259-266 (2012).
30. Aleksunes, L. M. and Klaassen, C. D.: Coordinated Regulation of Hepatic Phase I and II Drug-Metabolizing Genes and Transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-Null Mice. Drug Metab. Dispos., 40: 1366-1379 (2012).